LAKELAND, Fla.–(BUSINESS WIRE)–Publix’s sales for the three months ended March 28, 2026 were $16.1 billion, a 2% increase from $15.8 billion in 2025. The increase in sales for the three months ended March 28, 2026 compared to the three months ended March 29, 2025 was lower due to the impact of the Medicare maximum fair price (MFP) change effective January 1, 2026 which reduced drug prices for 10 drugs. The impact of the MFP change resulted in a decrease in sales. Comparable store sales for the three months ended March 28, 2026 remained unchanged.

Net earnings for the three months ended March 28, 2026 were $794 million, compared to $1 billion in 2025, a decrease of 21.5%. Earnings per share for the three months ended March 28,…